Athersys gets U.S., European patents for investigational stem cell therapy
Updated 4:39 p.m. CLEVELAND, Ohio — Biopharmaceutical company Athersys Inc. has received two patents that extend protection of its investigational stem cell therapy and how it is produced and used. Athersys said Wednesday it has been granted U.S. patent 7,659,118 , which covers its non-embryonic, multipotent stem cells and how they are isolated, expanded, made into a therapy and used. The …
[Read the full article here]Related News:
Athersys Gets U.S. Patent Covering Adult Stem Cell Composition …
Athersys Gets New Adult Stem Cell Patent
Athersys gets US patent covering adult stem cell composition & production